A comprehensive view of Metabolic Disorders. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Government & Public Policy Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

AstraZeneca partners with Vietnam’s Ministry of Health to promote existing and new programs to improve public awareness of diseases, prevention, early detection; programs to focus on lung health, cardiovascular/metabolic diseases, healthy lifestyles
Published: March 08, 2023 by Vietnam News Agency
Eli Lilly partners with Sosei Group to develop, commercialize small molecules that modulate novel G protein-coupled receptor targets associated with diabetes, metabolic diseases; firms to use Sosei Heptares' StaR technology and drug design platform
Published: December 20, 2022 by BioSpectrum Asia
Eli Lilly partners with biotech Nimbus Therapeutics to develop novel targeted therapies for metabolic diseases; Nimbus to use its computational drug discovery engine and Lily to assume development, global commercialization activities
Published: October 12, 2022 by SeeNews Pharmaceuticals
Amgen opens new 245,000 square-foot, nine-story R&D facility in San Francisco, California, with staff of 650; new facility to focus on discovering cancer, inflammatory disease, cardiometabolic disorder therapies
Published: October 07, 2022 by PR Newswire
Fitch upgrades Sanofi's outlook to positive from stable, reflecting its transition toward innovative pharmaceutical company and vaccine producer, away from cardio-metabolic leader with rare disease franchise, broad portfolio of legacy off-patent drugs
Published: May 24, 2022 by ENP Newswire

Ask us about our Government & Public Policy market view

Trending Chart

Interactive chart with headline count